Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,339 GBp
Change Today +19.00 / 1.44%
Volume 6.3M
As of 11:35 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for glaxosmithkline plc (GSK)

Currency in
Millions of US Dollars
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
NET INCOME7,940.36,859.48,287.94,201.9
Depreciation & Amortization1,361.51,328.01,116.01,189.2
Amortization of Goodwill and Intangible Assets808.1875.1844.7898.0
DEPRECIATION & AMORTIZATION, TOTAL2,169.62,203.11,960.72,087.2
Amortization of Deferred Charges----195.2175.3
(Gain) Loss from Sale of Asset-359.8-994.1-2,148.2-388.8
(Gain) Loss on Sale of Investment-907.2-24.4-484.8-227.2
Asset Writedown & Restructuring Costs512.3125.01,414.9312.6
Other Operating Activities2,483.61,773.21,279.2262.2
(Income) Loss on Equity Investments-22.9-44.2-65.6-45.7
Change in Accounts Receivable292.7279.024.4529.1
Change in Inventories-239.456.4-144.8-806.5
Change in Accounts Payable673.9269.9190.6138.7
Change in Other Working Capital-3,316.1-4,168.415.21,146.5
CASH FROM OPERATIONS9,529.06,670.311,011.07,891.5
Capital Expenditure-1,407.2-1,602.4-1,811.3-1,811.3
Sale of Property, Plant, and Equipment152.5103.770.159.5
Cash Acquisitions-402.5-3,407.6-376.6-158.6
Sale (Purchase) of Intangible Assets-256.1895.0-574.8-355.2
Investments in Marketable & Equity Securities1,571.9-115.9551.9175.3
CASH FROM INVESTING-170.8-4,011.3798.9-1,643.6
Short-Term Debt Issued68.62,657.4----
Long-Term Debt Issued--6,754.22,916.62,988.3
TOTAL DEBT ISSUED68.69,411.62,916.62,988.3
Short Term Debt Repaid-12.2-3,901.6-2,854.1-2,605.6
Long Term Debt Repaid-57.9-53.4-47.3-35.1
TOTAL DEBT REPAID-70.1-3,954.9-2,901.4-2,640.7
Issuance of Common Stock449.8631.2891.9254.6
Repurchase of Common Stock-3,395.4-3,857.3-2,361.7-507.7
Common Dividends Paid-5,192.9-5,436.9-5,610.7-5,859.2
Common and/or Preferred Dividends Paid---5,815.0----
TOTAL DIVIDEND PAID-5,192.9-5,436.9-5,610.7-5,859.2
Special Dividend Paid---378.1----
Other Financing Activities-1,361.5-1,524.6-2,498.9-2,445.5
CASH FROM FINANCING-9,501.6-5,109.1-9,564.1-8,210.2
Foreign Exchange Rate Adjustments-164.7-140.3-225.6128.1
NET CHANGE IN CASH-308.0-2,590.42,020.1-1,834.1

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,338.50 GBp +19.00

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $61.76 USD +0.78
Bristol-Myers Squibb Co $59.97 USD +0.36
Celgene Corp $119.56 USD -0.0241
Eli Lilly & Co $82.59 USD +0.78
Medtronic PLC $71.25 USD -0.30
View Industry Companies

Industry Analysis


Industry Average

Valuation GSK Industry Range
Price/Earnings 6.5x
Price/Sales 2.7x
Price/Book 9.1x
Price/Cash Flow 6.5x
TEV/Sales 2.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at